Trial Condition(s):

Sunscreening Agents

Sun Protection Factor Assay (SPF Assay 204/2016)

Bayer Identifier:

19204

ClinicalTrials.gov Identifier:

NCT02936544

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

To evaluate the Sun Protection Factor efficacy on human skin.

Inclusion Criteria
- Fitzpatrick Skin Type l, ll and/or lll for UVB testing. Fitzpatrick Skin Type ll, lll and/or lV for UVA testing.
 - Male and female.
 - Aged between 18-70 years old.
 - Good health as determined from the HRL SHF (Subject History Form).
 - Signed and dated Informed Consent Form.
 - Signed and dated HIPAA (Health Insurance Portability and Accountability Act) form.
 - An unambiguous MED (Minimal Erythema Dose) or MPPD (Minimal Persistent Pigment Darkening Dose)
Exclusion Criteria
- Subjects on test at any other research laboratory or clinic.
 - Known allergy or sensitivity to sunscreens, cosmetics and toiletries, topical drugs and/or ultraviolet light.
 - Pre-existing dermatologic conditions which have been diagnoses by a medical professional (e.g. psoriasis, eczema, etc.)which would interfere with this study.
 - Pre-existing other medical conditions (e.g. adult asthma, diabetes).
 - Treatment with antihistamines or corticosteroids within one week prior to initiation of the test.
 - Treatment with antibiotics within two weeks prior to initiation of the test.
 - Chronic medication which could affect the results of the study.
 - Known pregnant or nursing women.

Trial Summary

Enrollment Goal
11
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
BAY987521
Accepts Healthy Volunteers
Yes

Where to Participate

Loading...
Locations
Locations
Locations

Investigative Site

Union, United States, 07083

Trial Design